Notably vaccine-induced CD8 T cell responses to SARS-CoV-2 spike protein epitopes were comparable between lymphoma patients and healthy controls23, and elevated circulating CD8 + T cell counts were associated with survival in HM patients following COVID-19 infection24. The gene discussed is CD8A; the disease is lymphoma.